e-learning
resources
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Novel therapeutics for cystic fibrosis
Marcus Mall (Berlin, Germany)
Source:
ERS Webinar 2020: Novel therapeutics for cystic fibrosis
Number:
0
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Marcus Mall (Berlin, Germany). Novel therapeutics for cystic fibrosis. ERS Webinar 2020: Novel therapeutics for cystic fibrosis
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Sebnem Ozdogan - 12.01.2020 13:42
Well done
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
PDW1 Spirometry training programme: become a programme organiser
Related content which might interest you:
Genotype-specific small-molecule therapy for cystic fibrosis
Source: Breathe 2013; 9: 176-186
Year: 2013
Genomically-guided therapies: a new era for cystic fibrosis
Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases
Year: 2020
Update on new treatments for cystic fibrosis
Source: Virtual Congress 2020 – Updates in cystic fibrosis
Year: 2020
Targeting CFTR as a therapy for cystic fibrosis
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010
New cystic fibrosis therapy targets
Source: Research Seminar 2014 - Protein quality control in lung disease
Year: 2014
Cystic fibrosis: prospects for therapy of some class 1 mutations
Source: Annual Congress 2007 - Cystic fibrosis: will the new biology deliver?
Year: 2007
Genotype specific therapies for cystic fibrosis
Source: Annual Congress 2004 - New approaches to cystic fibrosis: from cells and molecules to novel therapies
Year: 2004
Novel therapeutics for CF
Source: International Congress 2019 – Future of cystic fibrosis care: insights from the Lancet Commission
Year: 2019
New vaccines for use in cystic fibrosis
Source: Annual Congress 2004 - New approaches to cystic fibrosis: from cells and molecules to novel therapies
Year: 2004
Neomacrolides in cystic fibrosis
Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease
Year: 2012
Potential therapeutic use of 12-Lipoxygenase inhibitors in the treatment of mucus overproduction in cystic fibrosis
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009
Formulation of dual modality nanoparticles to enhance tobramycin efficacy in cystic fibrosis
Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways
Year: 2013
Revisiting α1-antitrypsin therapy in cystic fibrosis: can it still offer promise?
Source: Eur Respir J 2007; 29: 229-230
Year: 2007
Lung inflammation in cystic fibrosis: an overlooked therapeutic target?
Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age
Year: 2020
Novel protein biomarkers of bronchiectasis in children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology
Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Year: 2012
Transition in cystic fibrosis
Source: International Congress 2017 – PG16 Transition of children and adolescents into adult care
Year: 2017
CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways
Source: Eur Respir Rev, 29 (156) 190068; 10.1183/16000617.0068-2019
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept